๐ฌDeep Research
CDNA โ CareDx ยท catalysts, narrative & risks
CareDx (CDNA) โ Research Snapshot as of 2026-10-03
Company context: CareDx is a Nasdaq-listed precision-medicine diagnostics company focused on genomics-based transplant diagnostics, testing services, products, and digital solutions [20]. As of early October 2026 it carries a market capitalization near $3.4โ3.5B and trades in the high-$60s (e.g., $67.15 on Oct 2, 2026) [5][6][20].
Key Recent Catalysts (last ~1โ3 months)
AI-assisted research from the K3vl4r desk โ not personalized investment advice. More research โ